187 related articles for article (PubMed ID: 37294531)
1. KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer.
Zhang C; Huang Z
Mol Biotechnol; 2024 Jun; 66(6):1446-1457. PubMed ID: 37294531
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
[TBL] [Abstract][Full Text] [Related]
3. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
Zhao H; Jiang R; Feng Z; Wang X; Zhang C
J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
[TBL] [Abstract][Full Text] [Related]
5. KAT2A succinyltransferase activity-mediated 14-3-3ζ upregulation promotes β-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells.
Tong Y; Guo D; Yan D; Ma C; Shao F; Wang Y; Luo S; Lin L; Tao J; Jiang Y; Lu Z; Xing D
Cancer Lett; 2020 Jan; 469():1-10. PubMed ID: 31610265
[TBL] [Abstract][Full Text] [Related]
6. PKM2 promotes glioma progression by mediating CTNNB1 expression.
Ma C; Feng Y; Zhong K; Wei J
Neurol Res; 2024 Jul; 46(7):583-592. PubMed ID: 38797679
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1.
Zhu Y; Lu F
BMC Cancer; 2024 Jun; 24(1):682. PubMed ID: 38835015
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer.
Dai T; Zhang X; Zhou X; Hu X; Huang X; Xing F; Tian H; Li Y
Clin Transl Med; 2022 Oct; 12(10):e1088. PubMed ID: 36229913
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
10. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer.
Li X; Zhang C; Zhao T; Su Z; Li M; Hu J; Wen J; Shen J; Wang C; Pan J; Mu X; Ling T; Li Y; Wen H; Zhang X; You Q
J Exp Clin Cancer Res; 2020 Aug; 39(1):172. PubMed ID: 32859246
[TBL] [Abstract][Full Text] [Related]
11. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
[TBL] [Abstract][Full Text] [Related]
12. PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer.
Wang C; Jiang J; Ji J; Cai Q; Chen X; Yu Y; Zhu Z; Zhang J
Sci Rep; 2017 Jun; 7(1):2886. PubMed ID: 28588255
[TBL] [Abstract][Full Text] [Related]
13. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
14. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
15. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
Xu Q; Dou C; Liu X; Yang L; Ni C; Wang J; Guo Y; Yang W; Tong X; Huang D
Biomed Pharmacother; 2018 Nov; 107():1692-1704. PubMed ID: 30257387
[TBL] [Abstract][Full Text] [Related]
16. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
[TBL] [Abstract][Full Text] [Related]
17. Salidroside Induces Apoptosis in Human Gastric Cancer Cells via the Downregulation of ENO1/PKM2/GLUT1 Expression.
Dai Z; Zhang X; Li W; Tang J; Pan T; Ma C; Guan Q
Biol Pharm Bull; 2021 Nov; 44(11):1724-1731. PubMed ID: 34471002
[TBL] [Abstract][Full Text] [Related]
18. RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion.
Xu Y; Chu L; Yuan S; Yang Y; Yang Y; Xu B; Zhang K; Liu XY; Wang R; Fang L; Chen Z; Liang Z
Cell Death Dis; 2017 Jun; 8(6):e2835. PubMed ID: 28569774
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis.
Li H; Xu H; Xing R; Pan Y; Li W; Cui J; Lu Y
Pathol Res Pract; 2019 Jun; 215(6):152409. PubMed ID: 31000383
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
